書籍詳細

序

P.8 掲載の参考文献

• i) ポール・マイヤーズ著, 石原俊訳:レナード・バーンスタイン, アルファ・ベータ, 東京, 1985

P.10 掲載の参考文献

• 1) Gross NJ:What is this thing called love?-or, defining asthma, Am Rev Respir Dis 121:203-204, 1980
  pubmed

• 2) Dunnill MS:The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 13:27-33, 1960
  pubmed

• 3) Reed CE:New therapeutic approaches in asthma. J Allergy Clin Immunol 77:537-543, 1986
  pubmed

• 4) 泉孝英編:特集喘息 1993 喘息治療の革命. 最新医学48(11), 1993

• 5) Mitsui S:Death from bronchial asthma in Japan. Sino-Jpn J Allerg Immunol 3:249-257, 1986

• 6) 佐野靖之ほか:OPINION 喘息死ゼロを目指して～内科～. アレルギー・免疫13:1466-1472, 2006

謝辞

P.22 掲載の参考文献

• i) 多田富雄:免疫・「自己」と「非自己」の科学, 日本放送出版協会, 東京, 2001

P.25 掲載の参考文献

• i) 谷口克:免疫, その驚異のメカニズム-人体と社会の危機管理, ウェッジ, 東京, 2000

P.28 掲載の参考文献

• 1) Asthma:The fact, ed by Lane DJ, Oxford University Press, New York, 1996

• 2) 鈴田達男:抗体産生機序. 診療と保険11:1414-1422, 1969

• 3) 多田富雄:免疫・「自己」と「非自己」の科学, 日本放送出版協会, 東京, 2001

• 4) Wardlaw AJ et al:Eosinophil. In:Bronchial Asthma:Mechanism and therapeutics, ed by Weiss EB et al, Brown and Company, Boston, 1997, pp258-270

目次 / Contents

P.34 掲載の参考文献

• 1) Weiss ST:Eat dirt-the hygiene hypothesis and allergic diseases. N Engl J Med 347:930-931, 2002
  pubmed

• 2) Busse WW et al:Asthma. N Engl J Med 344:350-362, 2001
  pubmed

• 3) 馬場実:小児アレルギー疾患の発症と展開予防と可能性について. アレルギー38:1061-1069, 1989

• 4) Asthma:the facts, ed by Lane DJ, Oxford University Press, New York, 1996

第1章 気管支喘息について

P.42 掲載の参考文献

• i) Bousquet J et al:Allergic Rhinitis and its Impact on Asthma(ARIA)2008 Update(in collaboration with the World Health Organizatlon, GA2 LEN and AllerGen). Allergy 63(s86):8-160, 2008

P.43 掲載の参考文献

• 1) Clinical Manifestation of Respiratory Disease, ed by Terry DJ, Mosby Year Book Medical Publishers, Chicago, 1984, p161

• 2) National Asthma Education and Prevention Program Expert Panel Report 2:Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health(NIH publication no. 97-4051), Bethesda, 1997

• 3) Bousquet J et al:Allergic Rhinitis and its Impact on Asthrma(ARIA)2008 Update(in collaboration with the World Health Organization, GA2 LEN and AllerGen). Allergy 63 (s86) :8-160, 2008

• 4) 浅本仁:気管支喘息へのアプローチ 第3版. 先端医学社, 東京, 2006

• 5) Davey G, Sedgwick P, Maier W et al:Association between migraine and asthma:matched case-control study. Br J Gen Pract 52:723-727, 2002
  pubmed

• 6) Global Initiative for Asthma(GINA), Global Strategy for Asthma Management and Prevention, updated 2011

• i) Nagel G, Weinmayr G, Kleiner A et al:Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood(ISAAC) Phase Two. Thorax 65:516-522, 2010

• ii) British Thoracic Society(BTS), Scottish Intercollegiate Guidelines Network(SIGN):British Guideline on the Management of Asthma, revised 2011

第2章 気管支喘息の起こる機序と原因

P.49 掲載の参考文献

• i) Nadif R et al:Heterogeneity of asthma according to blood inflammatory patterns, Thorax 64'374-380, 2009
  pubmed

P.50 掲載の参考文献

• i) Hastie AT et al:Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunool 125:1028-1036, 2010

P.55 掲載の参考文献

• i) Shapiro SM et al:An evaluation of the accuracy of Assess and MiniWright peak flowmeters. Chest 99:358-362, 1991
  pubmed

• ii) 日本人のピークフロー値 改訂版, 月岡一治監修, 共和企画, 東京, 2002

P.58 掲載の参考文献

• i) Juniper EF et al:The COAL Committee:Identifying'well-controlled'and'not well-controlled'asthma using the Asthma Control Questionnaire. Respir Med 100:616-621, 2006

P.61 掲載の参考文献

• i) Global Initiative for Asthma(GINA), Global Strategy for Asthma Management and Prevention updated 2010

• i) Turner-Warwick M:On observing patterns of airflow obstruction in chronic asthma, Br J Dis Chest 71:73-86, 1977
  pubmed

P.63 掲載の参考文献

• 1) Global Initiative for Asthma(GINA), Global Strategy for Asthma Management and Prevention updated 2011

• 2) Jariwalla G:Epidemiology of asthma and asthma death. In:Asthma, ed by Jariwalla G, MTP Press, Lancaster/Boston, 1988, pp11-58

• 3) British Thoracic Society(BTS), Scottish Intercollegiate Guidelines Network(SIGN):British Guideline on the Management of Asthma, revised 2011

• 4) Jonsson S et al:Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline. Chest 94:723-726, 1988
  pubmed

• 5) Horn BR et al:Total eosinophil counts in the management of bronchial asthma. N Engl J Med 292:1152-1155, 1975
  pubmed

• 6) Moss RB:Allergy evaluation in children:skin testing and RAST. Am J Asthma Allergy Pediatr 110:101-108, 1988

• 7) Sears MR et al:Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children, N Engl J Med 325:1067-1071, 1991
  pubmed

• 8) National Asthma Education and Prevention Program. Expert Panel Report 3:Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health/National Heart, Lung, and Blood Institute, 2007

• 9) 日本人のピークフロー値 改訂版, 月岡一治監修, 共和企画, 東京, 2002

• 10) National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 2:Guidelines for the Diagnosis and Management of Asthmat NIH Publication 97-4051;National Institutes of Health, Bethesda, MD, 1997

• 11) British Thoracic Society:The British Guidelines on Asthma Management:1995 Review and Position Statement. Thorax 52:S1-S20, 1998

• 12) Oda T et al:A comparison of the individual best versus the predicted peak expiratory flow in patients with chronic asthma, J Asthma 38:33-40, 2001

• 13) 医療者のための喘息とCOPDの知識, 泉孝英ほか編, 医学書院, 東京, 2007

第3章 気管支喘息の有病率と自然経過

P.73 掲載の参考文献

• 1) National Asthma Education and Prevention Program. Expert Panel Report 3:Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health/National Heart, Lung, and Blood Institute, 2007

• 2) British Thoracic Society(BTS), Scottish Intercollegiate Guidelines Network(SIGN):British Guideline on the Management of Asthma, revised 2011

• 3) Global Initiative for Asthma(GINA):Global Strategy for Asthma Management and Prevention, updated 2011

• 4) 喘息予防・管理ガイドライン2009(JGL 2009), 社団法人日本アレルギー学会 喘息ガイドライン専門部会監修, 協和企画, 東京, 2009

• 5) McFadden ER et al:Arterial-blood gas tension in asthma. N Engl J Med 278:1027-1032, 1968
  pubmed

• 6) Fallot RJ:Acute respiratory failure. In:Current Therapy, of Respiratory Disease, ed by Cherniack RM et al, Tronto, 1989, pp337-341

• 7) Scoggin CH:Acute asthma and status asthmatics. In:Clinical strategies in adult asthma, ed by Scoggin CH et al, Lea and Febiger, Philadelphia, 1982, pp34-69

• 8) Jonsson S et al:Comparison of the oral and intravenous routes for treating asthma, with methylpredrlisolone and theophylline. Chest 94:723-726, 1988
  pubmed

第4章 気管支喘息発症の過程 ( 誘発する因子と悪化させる因子 ) と合併症

P.90 掲載の参考文献

• i) Salpeter SR et al:Meta-analysis:respiratory tolerance to regular beta 2-agonist use in patients with asthma. Ann Intern Med 140:802-813, 2004
  pubmed

P.92 掲載の参考文献

• i) Johnson M et al:Alternative mechanisms for long-acting β2-adrenergic agonists in COPD. Chest 120:258-270, 2001

• ii) Barnes PJ:Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids. Eur Respir J 19:182-191, 2002

• iii) 新しい診断と治療のABC2-喘息, 泉孝英編最新医学社, 大阪, 2011

• iv) Roux FJ et al:Functional and binding characteristics of long-acting beta 2-agonists in lung and heart. Am J Respir Crit Care Med l53:1489-1495, 1996

• v) 久米裕昭:気管支拡張薬の使い方. 呼吸 22:461-466, 2003

P.95 掲載の参考文献

• i) Ziment I:Respiratory Pharmacology and therapeutics, Saunders, Philadelphia, 1978

P.97 掲載の参考文献

• 1) Peters SP et al:Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 363:1715-1726, 2010
  pubmed

P.105 掲載の参考文献

• i) オーストラリア治療ガイドライン委員会:喘息の長期的薬物治療, 呼吸器疾患治療ガイドライン, 浜六郎ほか監訳, NPO法人医薬ビジランスセンター, 大阪, 2001

P.116 掲載の参考文献

• i) Harrison TW et al:Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations:randomised controlled trial, Lancet 363:271-275, 2004

• i) Pauwels RA et al:The inhaled Steroid Treatment as Regular Therapy in early asthma(START)study:rationale and design. Control Clin Trials 22:405-419, 2001
  pubmed

• ii) Todd GR et al:Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 87:457-461, 2002

P.121 掲載の参考文献

• i) Kemp J et al:Safety of formoterol in adults and children with asthma:a meta-analysis, Ann Allergy Asthma Immunol 197:71-78, 2011

• ii) Thomas M:High-dose inhaled corticosteroids versus add-on long-acting β-agonists in asthma:an observational study. J Allergy Clin Immunol 123:116-121, 2009

• iii) Wechsler ME et al:Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma(LARGE trial):a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 374:1754-1764, 2009

P.123 掲載の参考文献

• i) 矢田純一:イラスト免疫学, メジカルビュー社, 東京, 1990

P.125 掲載の参考文献

• i) Brightbill HD et al. Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice. Clin Invest 120:2218-2229, 2010
  pubmed

P.128 掲載の参考文献

• 1) Global Initiative for Asthma(GINA):Global Strategy for Asthma Management and Prevention, updated 2011

• 2) Ziment I:Respiratory pharmacology and therapeutics, Saunders, Philadelphia, 1978

• 3) Nelson HS et al:The Salmeterol Multicenter Asthma Research Trial:a comparson of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129:15-26, 2006
  pubmed

• 4) Baxter JD et al:Hormone receptors. N Engl J Med 301:1149-1161, 1979
  pubmed

• 5) Barnes PJ et al:Efficacy and safety of inhaled corticosteroids. New developments, Am J Respir Crit Care Med 157:S1-S53, 1998
  pubmed

• 6) National Heart, Lung and Blood Institute. Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention:NHLBI/WHO Workshop Report, NIH Publication 95-3659;National Institute of Health:Bethesda, MD, 1995

• 7) British Thoracic Society:The British Guidelines on Asthma Management:1995 Review and Position Statement. Thorax 52:S1-S20, 1998

• 8) Oda T et al:A comparison of the individual best versus the predicted peak expiratory flow in patients with chronic asthma. J Asthma 38:33-40, 2001

• 9) Greenberger PA:Corticosteroids in asthma, Rationale, use, and problems. Chest 101: 418S-421S, 1992
  pubmed

• 10) 勝正孝ほか:副腎皮質ステロイド剤の作用と使い方, 日本アップジョンKK, 東京, 1983

• 11) Barnes PJ:Inhaled glucocorticoids for asthma. N Engl J Med 332:868-875, 1995
  pubmed

• 12) 新しい診断と治療のABC2-喘息, 泉孝英編, 最新医学社, 2011

• 13) 小児気管支喘息治療・管理ガイドライン2012, 濱崎雄平ほか監修, 日本小児アレルギー学会, 協和企画, 東京, 2011

• 14) 喘息予防・管理ガイドライン2009(JGL 2009), 日本アレルギー学会, 協和企画, 東京, 2009

• 15) 宮川武彦:吸入デバイス-患者嗜好を考慮して-. 呼吸療法 2:64-73, 2010

• 16) British Thoracic Society(BTS), Scottish Intercollegiate Guidelines Network(SIGN):British Guideline on the Management of Asthma, revised 2011

• 17) Partridge MR etα1:Attitudes and actions of asthma patients on regular maintenance therapy:the INSPIRE study. BMC Pulm Med 6:13, 2006

• 18) 足立満, 広瀬敬:吸入ステロイド薬/長時間作用性吸入β2, 刺激薬配合剤. 日本内科学会雑誌 99:1536-1541, 2010

• 19) 久米裕昭:気管支拡張薬の使い方. 呼吸 22:461-466, 2003
  Medical*Online

• 20) National Asthma Education and Prevention Program. Expert Panel Report 3:Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health/National Heart, Lung, and Blood Institute, 2007

• 21) 大田健:IgE抗体陽性難治性喘息に対する治療戦略を探る. 抗体治療時代の気管支喘息治療の新たなストラテジー, 大田健編, 先端医学社, 東京, 2011, pp136-141

• 22) Busse WW et al:Randomized trial of omalizumab(anti-IgE)for asthma in inner-city children. N Engl J Med 364:1005-1015, 2011
  pubmed

• 23) Bousquet J et al:Sublingual-swallow immunotherapy(SLIT)in patients with asthma due to house-dust mites:a double-blind, placebo-controlled study. Allergy 154:249-260, 1999

第5章 気管支喘息の診断と鑑別診断

P.140 掲載の参考文献

• i) Hodder R et al:Management of acute asthma in adults in the emergency department; nonventilatory treatment. CMAJ 182:E55-E67, 2010
  pubmed

• ii) Global Initiative for Asthma(GINA):Global Strategy for Asthma Management and Prevention, updated 2011

P.142 掲載の参考文献

• i) Global Initiative for Asthma(GINA):Global Strategy for Asthma Management and Prevention, updated 2010

P.143 掲載の参考文献

• i) Chapman KR et al:Single maintenance and reliever therapy(SMART)of asthma:a critical appraisal. Thorax 65:747-752, 2010
  pubmed

• ii) 浅本仁ほか:気管支喘息の急性増悪の予後に対するサルメテロール/フルチカゾンプロピオン酸エステル50μg/500μg配合剤吸入療法の有用性. 日本臨床内科医会会誌 25:114-120, 2010

P.144 掲載の参考文献

• 1) Asthma Management Handbook 2006, ed by Belby J and Guidelines Committee Australia, National Asthma Council Australia, 2006

• 2) National Asthma Education and Prevention Program. Expert Panel Report 3:Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health/National Heart, Lung, and Blood Institute, 2007

• 3) 喘息予防・管理ガイドライン2009(JGL 2009), 日本アレルギー学会, 協和企画, 東京, 2009

• 4) British Thoracic Society(BTS), Scottish Intercollegiate Guidelines Network(SIGN):British Guideline on the Management of Asthma, revised 2011

• 5) Global Initiative for Asthma(GINA):Global Strategy for Asthma Management and Prevention, updated 2011

• 6) Bateman ED et al:Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J ResPir Crit Care Med 170:836-844, 2004
  pubmed

• 7) National Asthma Education and Prevention Program Expert Panel Report 2:Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health(NIH publication no. 97-4051), Bethesda, 1997

第6章 気管支喘息の重症度

P.154 掲載の参考文献

• 1) National Asthma Education and Prevention Program. Expert Panel Report 3:Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health/National Heart, Lung, and Blood Institute, 2007

• 2) British Thoracic Society(BTS), Scottish Intercollegiate Guidelines Network(SIGN):British Guideline on the Management of Asthma, revised 2011

• 3) Spector SL et al:Practice parameter for the diagnosis and treatment of asthma. J Allergy Clin Immunol 96:174-181, 1995

• 4) Hodder R et al:Management of acute asthma in adults in the emergency department; nonventilatory treatment. CMAJ 182:E55-E67, 2010
  pubmed

• 5) Global Initiative for Asthma(GINA):Global Strategy for Asthma Management and Prevention, updated 2011

第7章 気管支喘息治療薬

P.171 掲載の参考文献

• 1) オーストラリア治療ガイドライン委員会:喘息の長期的薬物治療, 呼吸器疾患治療ガイドライン, 浜六郎ほか監訳, NPO法人医薬ビジランスセンター, 大阪, 2001

• 2) Asthma Management Handbook 2006, ed by Belby J and Guidelines Committee Australia: National Asthma Council Australia, 2006

• 3) Asthma:the facts, ed by Lane DJ, Oxford University Press, NewYork, 1996

• 4) International consensus report on diagnosis and treatmant of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, Maryland 20892. Publication no, 92-3091, Eur Respir J 5 :601-641, 1992

• 5) British Thoracic Society(BTS), Scottish Intercollegiate Guidelines Network(SIGN):British Guideline on the Management of Asthma, revised 2011

• 6) Global Initiative for Asthma(GINA):Global Strategy for Asthma Management and Prevention, updated 2011

第8章 気管支喘息発作の予防と治療 - 喘息は管理 ( コントロール ) できる - ( 世界のガイドラインを参考に )

P.188 掲載の参考文献

• i) Rey E et al:Asthma in pregnancy. BMJ 334:582-585, 2007
  pubmed

• ii) National Heart, Lung, and Blood Institute:NAEPP expert panel report. Managing asthma during pregnancy:recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 115:34-46, 2005

• iii) British Thoracic Society(BTS), Scottish Intercollegiate Guidelines Network(SIGN): British Guideline on the Management of Asthma, revised 2011

• iv) Murphy VE et al:Asthma exacerbations during pregnancy:incidence and association with adverse pregnancy outcomes. Thorax 61:169-176, 2006

• v) Hodder R et al:Management of acute asthma in adults in the emergency department; nonventilatory treatment. CMAJ 182:E55-E67, 2010

P.190 掲載の参考文献

• i) Hesselmar B et al:Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 29:611-617, 1999
  pubmed

P.191 掲載の参考文献

• 1) 末次勤:重症喘息とアスピリン. Excerpta Medica News Letter. Allergy UPdate 1:16, 1990

• 2) オーストラリア治療ガイドライン委員会:喘息の長期的薬物治療. 呼吸器疾患治療ガイドライン, 別府宏囲ほか監訳, NPO法人医薬ビジランスセンター, 大阪, 2001, pp97-115

• 3) 医療者のための喘息とCOPDの知識, 泉孝英ほか編, 医学書院, 東京, 2007

• 4) Asthma:The fact, ed by Lane DJ, Oxford University Press, New York, 1996

• i) Miller BD:Depression and asthma:Apoteitially lethal mixture, J Allergy Clin Immunol 80:481-486, 1987
  pubmed

第9章 気管支喘息急性発作時の救急外来における治療と管理 - 在宅管理も含めて -

P.200 掲載の参考文献

• 1) 新実彰男:慢性咳鰍の診断と治療Overview. アレルギー56:85-88, 2007

• 2) Glauser FL:Variant asthma. Ann Allergy 30:457-459, 1972
  pubmed

• 3) 藤村政樹:医学と医療の最前線, 咳喘息とアトピー咳. 日本内科学会雑誌 93:1200-1205, 2004

• 4) 咳鰍に関するガイドライン, 日本呼吸器学会咳徽に関するガイドライン作成委員会編, 日本呼吸器学会発行, 2005

• 5) 藤村政樹:慢性咳順を診る, 医薬ジャーナル社, 大阪, 2002

• 6) Gibson PG et al:Chronic cough:eosinophilic bronchitis without asthma. Lancet i:1346-1348, 1989
  pubmed

• 7) Irwin RS et al:Postnasal drip and cough. Clin Notes Respir Dis 18:11-12, 1980
  pubmed

第10章 患者 - 医療者間のパートナーシップと自己管理 - 良きパートナーシップが喘息管理計画成功の鍵 ! -

P.208 掲載の参考文献

• 1) 浅本仁ほか:非ステロイド系抗炎症薬による致死的発作例の臨床的検討. アレルギー48: 1230-1237, 1999

第11章 特殊な気管支喘息とその治療

P.211 掲載の参考文献

• 1) Turner-Warwick M:On observing patterns of airnow obstruction in chronic asthma. Br J Dis Chest 71:73-86, 1977

第13章 喘息死およびその危険因子と喘息管理における医療者の役割

P.230 掲載の参考文献

• 1) Suissa S et al:Use of anti-inflammatory therapy and asthma mortality in Japan. Eur. Respir J 21:101-104, 2003
  pubmed

• 2) Haalboom JR et al:Effect of fenoterol on plasma potassium and cardiac ectopic activity. Lancetii :45, 1989
  pubmed

• 3) Garrett JE et al:Risk of severe life threatening asthma and βagonist type:an example of confounding by severity. Thorax 51:1093-1099, 1996

• 4) Global Initiative for Asthma(GINA):Global Strategy for Asthma Management and Prevention, updated 2011

• 5) British Thoracic Society(BTS), Scottish Intercollegiate Guidelines Network(SIGN):British Guideline on the Management of Asthma, revised 2011

• 6) Hadar P et al:Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 360:973-984, 2009